Skip to main content
. 2011 Sep 28;3(4):3762–3772. doi: 10.3390/cancers3043762

Table 2.

Levels of different tocopherols (T) in plasma, prostate and tumors from SCID mice treated with dietary γ-TmT.

Treatment Plasma (μM ± SE) Prostate (μmol/kg ± SE) Tumor (μmol/kg ± SE)

α-T γ-T δ-T α-T γ-T δ-T α-T γ-T δ-T
Control 0.73 ± 0.08 0.61 ± 0.09 0.11 ± 0.02 3.76 ± 1.14 0.13 ± 0.05 0.06 ± 0.03 2.95 ± 0.26 0.29 ± 0.01 0.19 ± 0.01
0.1% γ-TmT 3.80 ± 1.41 0.71 ± 0.09 0.13 ± 0.01 3.37 ± 0.84 0.33 ± 0.06 0.19 ± 0.03 3.10 ± 0.50 0.65 ± 0.03 0.37 ± 0.02
0.3% γ-TmT 2.87 ± 1.08 0.99 ± 0.14 0.18 ± 0.03 4.50 ± 0.84 0.92 ± 0.19 0.48 ± 0.11 3.26 ± 1.02 0.64 ± 0.17 0.36 ± 0.07
0.5% γ-TmT 5.55 ± 1.57 1.18 ± 0.24 0.23 ± 0.06 2.57 ± 0.74 0.63 ± 0.16 0.41 ± 0.09 2.16 ± 0.57 0.33 ± 0.03 0.22 ± 0.01

Plasma, prostate and tumors from the experiment described in Figure 1 were collected for analysis of different tocopherols (T). Levels of α-T, γ-T and δ-T were determined according to the Materials and Methods. The detection limit of each tocopherol in our analysis was 0.02 ng.